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Clinical evidence exists which suggests that normal pigment 
cell (melanocyte) function is subject to hormonal influences, 
but the nature of these interactions at a cellular level is poorly 
understood. W e have investigated the effects of the vitamin 
D-derived secosteroid hormone la-25,dihydroxyvitamin 0 3 
(1 ,2S(OHh03)' the pituitary-derived peptide alpha-mela-
nocyte stimulating hormone (a-MSH), and the sex steroid 
beta-estradiol on melanocytes cultured from normal human 
foreskin. 
Human melanocytes specifical ly internalized 1,25(OH)z 0 3 
with high affinity (Kd 0.5 - 0.8nM). Incubation with 
1,25(OH)z03 (10- 9M) for 48 h resulted in a 100% increase in 
25-hydroxyvitamin 03-24-hydroxylase activity and a 50% in-
crease in tyrosinase activity. There was no significant effect of 
Severa l hormones are thought to influence skin pigmenta-tion in vivo. These include sex steroids [1] and pituitary derived pro-opiomelanocortin related peptides [2] . It has been suggested that the hormonal form of vitamin D [1(X-25,dihydroxyvitamin D3 (1,25(OH)2D3)) may also 
influence pigment cell fun ction. This metabolite, which is pro-
duced in relatively large concentrations in the kidney (3], is also 
synth esized by epidermal keratinocytes [4) and by some melanoma 
cell lines [5]. 1 ,25(OH)2D3 binds to specific receptors in some mela-
noma cel l lines [6,7) and exerts profound effects on their prolifera-
tive and melanogenic activities in vitro [6,8,9] and in vivo [10] . 
Pavlovitch et al [11) showed that the tyrosinase [E.C. 1.14.18.1] 
response of rat skin to a dose of ultraviolet irradiation was dependent 
on the vitamin D status of the animal. 
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Abbreviations: 
(X-MSH-alpha-mclanocyte stimulating hormone 
cAMP - cycl ic adenosine ll1onophosphate 
CT - cholera toxin 
EMEM - Eagles minimal essential medium with Earle's sa lts 
FCS - feta l ca lf serum 
IBMX - isobuty lmethylxanthine 
mEMEM - modified EMEM 
PMA - phorbol-12-myristate-13-acetate 
1 ,25(OH)2DJ - 1a-25, dihydroxyvitamin DJ 
25{O H)DJ - 25-hydroxyvitamin DJ 
24-hydroxylase - 25-hydroxyvitarnin DJ-24-hydroxylasc 
1,2S(OH)z03 on intracellular cyclic adenosine monophosphate 
(cAMP). In contrast to 1,2S(OH)zD3, a-MSH at a concentra-
tion of 5X lO- 7M caused a sevenfold increase in intracellular 
cAMP after 12 min but only a modest increase « 20%) in 
melanocyte tyrosinase activity after 48 h. Incubation with beta-
estradiol for 24 h caused a dose-dependent increase in tyrosinase 
activity. The maximal response varied from 145%-213% of 
basal activity depending on the donor source~ 
These results indicate that melanocytes fro m normal 
human foreskin in culture have the capacity to respond di-
rectly to several hormones. They also suggest that these cells 
form a useful model to study the effect of various hormones 
on pigment cell function. ] I'lIIest Dermatol 91 :593 -598, 
1988 
The mechanisms involved in the actions of these hormones on 
pigmented cells are currently unclear. Some information is available 
from studies involving melanoma celis, but the hormonal res]?onses 
of these celis are variable, even in qualitative terms [9,12 - 14J. The 
recent development of methods for the cu lture of melanocytes from 
normal skin [15 ,16] has faci litated the study of the effects of 
1,25(OH)zD and other hormones on the function of these cells. 
MATERIALS AND METHODS 
Materials Eagle's minimal essential medium with Earle's salt 
(EMEM) ' was purchased fro m Gibco Laboratories (Grand Island, 
NY) . Iscove's medium (containing bovine serum albumin), fetal 
calf serum (FCS), charcoal-stripped FCS, and trypsin were al l pur-
chased from Flow Laboratories Inc. (Sydney, Australia). Plastic tis-
sue culture dishes and fl asks were obtained from Nll11C Inter Med 
(Roskilde, Denmark) and Cornin g Ltd., Laboratory Division (Staf-
fordshire, UK). Phorbol-12-myristate-13-acetate (PMA), cholera 
toxin (CT), isobutyl methyl xanthine (IBMX), bovine serum albu-
min, ethylene diamine tetra-acetic acid disodium salt (EDT A), gen-
eticin , DNA standard, soy bean trypsin inhibitor, phenylthiourea, 
beta-estradiol, and synthetic human (X-MSH were all purchased 
from Sigma Chemical Co. (St. Louis, MO). 25-Hydroxyvitamin D3 
and 1 ,2S(OH)zD3 were generously provided by Roche Pty Ltd (Dee 
Why, NSW, Australia). Dihydroxyphenylalanine (DOPA) and re-
agents used in buffers were obtained from Calbiochem Behring Co. 
(Kingsgrove, NSW, Australia). Bio-Gel HTP was purchased from 
Biorad, Australia . 1(X,25-hydroxy-(26,27 -methyl-3H] cholecal-
ciferol (1 80 Ci/mmol) , 25-hydroxy-[26,27-methyPH] cholecal-
cifero l (20 Ci/mmol) , and L-[3,S-3H]-tyrosine (50-60Ci/mmol) 
were obtained frol11 Amersham Australia Pty . Ltd. (Sydney, Austra-
lia). So luene-350, Dimilume-30, Hionic-Fluor, and Instagel were 
purchased froul Packard Instruments (Downers Grove, IL) . The 
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sonifier cell disrupter was purchased from Branson Sonic Power 
Company (Connecticut). 
Culture Conditions Human melanocyte cultures were derived 
from neonatal foreskins as described by Eisinger and Marko [15J 
with minor modifications. The cultures were routinely grown in 80 
cm2 tissue culture flasks. The growth medium consisted of EMEM 
containing 2 mM glutamine, 2.25 g/I sodium bicarbonate, 16 nM 
PMA, 10 nM cholera toxin, and 5% v/v heat-inactivated FCS, pH 
7.2. All cultures were treated for at least 3 d with 100 jlg/ml geneti-
cin [17J. 
Experimental Conditions Melanocytes near confluence were 
detached from the culture flasks with trypsin (0.05% w Iv) and 
EDTA (0.02% w Iv) in phosphate buffered saline. These cells were 
pelleted, resuspended in growth medium, and seeded at a density of 
1 - 4 X 104 cells/ cm2 on to uncoated plastic 24 well plates or flasks 
except where otherwise indicated [18]. After incubation for 48 h the 
growth medium was replaced with EMEM devoid ofPMA and CT 
(mEMEM) but containing up to 5% FCS which had been charcoal 
treated (charcoal-stripped FCS) in an attempt to remove endoge-
nous steroids [7]. After preincubation with mEMEM for the stated 
times, the cells were either analyzed for 1,25(OH)2D3 uptake or 
cyclic adenosine monophosphate (cAMP) production, or incubated 
for a further 24-48 h with 1,25(OHhD3, a-MSH or with beta-es-
tradiol. 1,25 (OH)2D3 and beta-estradiol were added in absolute 
ethanol (0.1 % final concentration), while a-MSH was added in 
phosphate buffered saline (1 % final concentration). Control wells 
received the appropriate vehicle. At the end of the third incubation 
period (up to 48 h) tyrosinase and 24-hydroxylase were measured as 
described below. 
Uptake of(3H]1,25(OH)2D3 by Intact Cells These studies were 
performed in order to determine whether the observed effects of 
1,25(OHhDJ were receptor-mediated. After preincubation in 
mEMEM for 24 h the melanocytes were detached and collected in 
phosphate buffered saline containing 1 mg/ml soy bean trypsin 
inhibitor. The cells were pelleted, washed once in binding buffer 
(EMEM containing 2 mM glutamine, 20 mM Hepes, 0.05% bovine 
serum albumin, pH 7.4), and resuspended in fresh binding buffer. 
An aliquot of the cell suspension was counted in a hemo-cytometer. 
The volume was adjusted to give a final cell concentration of 0.2 -
1.0 X 106 cells/ml. Uptake of[3HJ 1,25(OHhD3 by intact cells was 
measured by the method of Manolagas and Deftos [19J modified as 
previously described [9]. Briefly, 500 jll aliquots of the cell suspen-
sion were added to poly carbonate tubes containing either 
[3H]1 ,25(OHhD3 alone (total binding) or [3HJ-l ,25(OH)2D3 and a 
SOD-fold excess of unlabeled 1,25(OHhD3 (non-specific binding). 
The tubes were incubated at 37" C with gentle shaking for 3 h when 
maximum binding occurred (data not shown). The cell suspension 
was pelleted and washed 3 times in 1 ml ice cold isotonic wash 
buffer (0.25 M sucrose, 0.01 M Tris-HCI, 0.025 M KCI, 0.001 M 
MgClz, 0.001 M EDTA, 0.012 M thioglycerol, 0.5% w/v bovine 
serum albumin, {'H 7.4). The cells were resuspended in 500 jll 
isotonic wash buffer and an aliquot was taken for assessment of cell 
viability with trypan blue. This was found to be greater than 90% in 
all cases. Another aliquot was pipetted into a liquid scintillation vial 
containing an equal volume of Soluene-350. The mixture was 
heated to 50°C for 4 h, cooled and counted in 15 ml Dimilune-30 
scintillant in a Packard 360 C liquid scinti llation counter (Downers 
Grove,IL). 
Hydroxylapatite Assay ofNucIear Bound 1,25(OH)2DJ In-
tact cells were incubated at 37 °C for 3 h with PH] 1,25(OHhD3 in 
the presence or absence of excess unlabeled ligand as described 
above. All subsequent procedures were performed at ~ O C. The cells 
were washed with ice cold isotonic wash buffer and lysed by incuba-
tion with 1 ml hypertonic buffer (0.3 M KCI, 0.01 M Tris-HCI, 
0.0015 M EDTA, and 0.005 M dithiothreitol, pH 7.4 containing 
0.5% v /v Triton X-I 00) for 30 min with vigorous vortexing every 
15 min. The internalized, receptor bound 1,25(OHhD3 was mea-
sured by a modification of the method ofWecksler et al [20J. One 
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milliliter of a hydroxylapatite slurry (50% v /v in 0.01 M Tris-HClj 
0.1 M KCI, pH 7.5) was added to the lysed cells and the mixture Wa 
incubated for 15 min with vorte~ing every 5 min. The mixture wa! 
centnfuge~ at 1.000 g for 5 m1l1 and the hydroxylapatite pellet 
washed r:"lce .w.lth buffer (0.01 M Tris-HCI, 0.001 M EDTA, pH 
7.5). RadIOactiVIty was extracted from the pellets by the addition of 
1 n;1 ethanol an~ 0.5 ml dichloromet~ane. The. mixture was kept at 
30 C for 30 mm, vortexed several times durmg this period, and 
centnfuged at 1000 g for 5 min. The supernatant was decanted into 
liquid scintillation vials. This procedure was repeated once and the 
sup~rna~al:ts for each tube pooled. After drying in air overnight the 
radlOaCtlVlty was counted in 10 ml Instagel. 
24-Hydroxylase Cells (approximately 3X1 04 cells/ cm2) were in-
cubated for 48 h in mEMEM and then for a further 48 h in mEMEM 
containing various concentrations of 1 ,25(OH)zD3' The cell mOn_ 
olayers were washed twice with phosphate buffered saline and 24-
hydroxylase was measured using high performance liquid chroma_ 
tography as previously described [5] . 
Tyrosinase Activity Tyrosinase activity, which is believed to be 
closely correlated with melanogenesis in melanocytes [18,21J , Was 
measured in cells (approximately 1.5 X 104 cells/cm2) that had 
been preincubated for up to 48 h in mEMEM then incubated for a 
further 24-48 h in mEMEM or Iscove's medium cOl\taining the 
hormone under study. Although EMEM is a standard culture me-
dium for melanocytes [15J, the Iscove's medium used in these ex-
periments contains bovine serum albumin and phospholipids that 
enhance the solubility of steroids and steroid-like compounds such 
as 1,25(OH)2D3 (Mason et ai, unpublished observations). Qualita_ 
tively similar results were obtained in the presence of either me-
dium. After this incubation period, cell extracts were prepared by 
lysing in a phosphate buffer containing 0.1 % Triton X-1 00 [9] and 
tyrosinase activity was measured by the method of Pomerantz [22]. 
This method measures the amount of [3HJH20 released from [3H] 
tyrosine by tyrosinase in the presence of a catalytic amount of 
DOPA cofactor. All values were corrected for non-enzymic hy_ 
droxylation of [3H] tyrosine by subtracting the amount of [3H]H20 
formed by cell extracts containing ImM phenylthiourea [18J. 
cAMP Measurements After preincubation with mEMEM for 
48 - 72 h the cell monolayers (containing approximately 1 X 104 
cells/cmZ) were washed twice with phosphate buffered saline and 
incubated for 10 min at room temperature in mEMEM containing 
2% charcoal stripped FCS and 10 111M IBMX [23J. 1,25(OH)2D3 or 
Q-MSH were then added and the cells were incubated for a further 
12 min at room temperature. The medium was aspirated, the cells 
extracted with absolute ethanol and an aliquot assayed for cAMP by 
a radioimmuno-assay technique using [,25IJcAMP and a laboratory 
generated antibody [24J. Another aliquot of the cell extract was 
diluted in phosphate buffered saline, sonicated, and assayed for 
DNA content by the method of Kapuscinski and Skoczylas [25] 
using denatured, highly polymerized DNA from calf thymus as a 
standard. Although the concentration of IBM X used in these exper-
iments is relatively high, previous studies in this laboratory have 
shown that under these conditions, hormonal effects on cAMP pro-
duction are demonstrable in a wide variety of cell types, including 
pigment cell s [9,23,24J. 
Statistical Analysis Groups were compared using Student's t-test 
for unpaired data. 
RESULTS 
Specific Uptake of PH] 1,25(OH)zDJ by Melanocytes Intact 
melanocytes accumulated PH] 1,25(OH)zD3 in a specific, saturable 
manner (Fig 1). In order to obtain a quantitative measure of the 
translocation rrocess [19], this data was analyzed by the method of 
Scatchard [26 . A straight line was obtained with an apparent disso-
ciation constant (Kd) for the 1,25(OH)zDj intracellular binding site 
ofO.811M and a total concentration (N max) of7 fmol/l06 cells (Fig 
1, inset). 
Scatchard analysis of the data generated with nuclear bound 
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Figure 1. Specific [3H)1 ,2S(OHhD3 uptake by intact human melanocytes. 
Cell suspensions containing 0.12 X 106 cells/SOO III were incubated with 
increasing concentrations of[3H)l,2S(OHhD3 in the absence or presence of 
excess unlabeled 1,2S(OH)2D3' Specific uptake was calculated by subtract-
ing uptake in the presence of unlabeled material from uptake in the absence 
of unlabeled material. ItlSet: Scatchard analysis of data. 
1,25(OH)2D3 gave very similar results. The apparent dissociation 
constant was 0.5 1 nM, while the total concentration was 10 
fmol/l06 cells (data not shown). 
In the presence of 2 nmol unlabeled 1,25(OH)2D3 the specific 
uptake of [3H]1,25(OH)2D3 was reduced by approximately 50%, 
whereas at least 1000-fold molar excess of 25-hydroxyvitamin D3 
was required to effect a similar reduction in uptake (Fig 2). 
Effects of 1,25(OH)2D3 on 24-Hydroxylase Activity, Tyro-
sinase Activity and Melanocyte Numbers Incubation of mel a-
nocytes with 10- 10 or 10- 9 M 1,25(OHhD3 for 48 h resulted in a 
twofold increase in 24-hydroxylase activity (Fig 3). This response 
was biphasic with a maximal increase at 10- 9 M 1,25(OH)2D3 
(Fig 3). 
Incubation with 1,25(OHhD3 (10- 10 - 10- 8 M) for 48 h in 
rnEMEM resulted in a dose-dependent increase of tyrosinase activ-
ity (Fig 4a). Under these conditions the maximal tyrosinase re-
sponse in melanocytes from three donors varied between 136% and 
160% of control values. If melanocytes were examined after only 24 
h incubation with 1,25(OHhD3 in mEMEM the increases in tyro-
sinase activity were smaller and varied between 105% and 136% of 
control values, depending on the donor source (data not shown). 
Qualitatively similar results were obtained when the melanocytes 
were incubated with 1,25(OH)2D3 in Iscove's medium, except that 
increases of 147% - 170% (at 10- 9 M) of the control values were 
seen after only 24 h (p < 0.01). 
Incubation with similar concentrations of 1 ,25(OHhD3 also re-
sulte d in a decrease in cell numbers (Fig 4b). In three experiments, 
the magnitude of the decrease in cell numbers induced by 
1,25(OH)2D3 at various concentrations was negatively related to 
the increase in tyrosinase activity (n = 9, r = 0.744, P < 0.025). 
1,25(OH)2D3 had no significant effect on intracellular cAMP 
levels at any of the concentrations examined (data not shown). 
Effects ofa-MSH on cAMP Production and Tyrosinase Ac-
tiviry Incubation of melanocytes with a-MSH (5 X 10- 7 M) for 
12 m in resulted in a sevenfoll:i increase in intracellular cAMP con-
centrations (Fig 5). 
In contrast, incubation of melanocytes with the same concentra-
tion of a-MSH (5 X 10- 7 M) for 48 h increased tyrosinase activity 
by only 12 ± 3% above control values (n = 3; P < 0.05) . a-MSH at 
this concentration and over this time period had no effect on cell 
nurnbers. 
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Figure 2. Competition of two vitamin 0 3 metabolites for the 
1,2S(OH)2D3 binding site in intact human melanocytes. Cell suspensions 
containing O.S X 106 ce lls/ SOO III were incuba,ted with 20 pg 
[3H]1 ,2S(OH)2D3 and with increasing concentrations of unlabeled 
1 ,2S(OH)203 (e-e) or 2S(OH)D3 (0-0). Each poitlt represents the mean 
of duplicate determinations. The values on the abcissa refer to the amounts of 
the two metabolites added to each tube (per 500 Ill ). 
Effect of Beta-estradiol on Tyrosinase Activity and Melano-
cyte Numbers Incubation of melanocytes with beta-estradiol 
(10- 12 - 10- 9 M) for 24 h resulted in a dose-dependent stimulation 
of tyrosinase activity and a 50% reduction in cell numbers with 
10- 10 - 10- 9 M beta-estradiol (Fig 6). As with 1,25(OH)2D3 there 
was a negative correlation between the decrease in cell numbers and 
the increase in tyrosinase activity (n = 15, r = -0.7257, P < 0.01). 
The results in Table I show that the magnitude of the beta-estra-
diol-induced tyrosinase response was similar in cells from the same 
donor at different passages (cell line 0109, passages 5 and 6) but may 
differ between donors. 
DISCUSSION 
On the basis of studies in intact animals 1,25(OHhD3' a-MSH, and 
sex steroids are regarded as probable regulators of pigment cell func-
tion [2,11,27). The evidence that these hormones affect pigment 
cell function in vitro has been limited largely to studies with mela-
noma cell lines [8,9,12). 
In some respects the results obtained with 1,25(OHhD3 in 
human melanocytes are similar to those reported in human mela-
noma cells [5 -7,9]. Human melanocytes bind 1,25(OHhD3 with 
affinities similar to those reported for human and animal melanoma 
cells and for other types of skin cells [28). They respond to this 
hormone with a large increase in 24-hydroxylase activity. This 
"classical" response has been shown in other cell s to be a receptor-
mediated event [29]. The lack of cAMP responses to 1,25(OHhD3 
t 
10.10 \0 ·\1 10,8 
1,2S (OHI2 D3 IM) 
Figure 3. Effect of 48-h preincubation wi th 1,2S(OHhD3 on the 24-hy-
droxylase activities of human melanocytes. The cells were incubated with 
[3H)2S(OH)D3 (0.4 IlCi/ml; specific activity 2 Ci/mmol) for 90 min. Bar 
heights indicate the mean ± 1S0 of triplicate determinations. Asterisks refer 
to differences between treated and control va lues: .p < 0.01; •• p < 0.001. 
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Figure 4. Effect of 1 ,25(OH)2D, on the tyros inase activi ti es and cell num-
bers of human melanocytes. Melanocytes were incubated for 48 h with 
1 ,25(OH)2D" in mEMEM then assayed for tyrosinase activity (A) or counted 
(B). Bar heights indicate the mean ± l SD of triplica te determinations (A ) and 
mean ± 1 SD of triplicate determinations (0 and 10- 8 M) (B) from one 
representative experiment. Asterisks refer to differences between treated and 
control va lues: ' p < 0.025; " p < 0.005; "'p < 0.001. 
is in accord with the observation that the effects of steroid hormones 
are generally not mediated via the adenylate cyclase pathway [30J . 
It has previously been shown with melanoma ce ll s [8,9J that the 
increase in tyrosinase activity induced by l ,25(OH}2D3 is generally 
accompanied by a decrease in cell proliferation and it has been sug-
Figure S. Effect of a-MSH on intrace ll ular cAMP levels in human melano-
cytes. Bar heights indicate the mean ± 1 SD for tripl icate determinations 
from one representative experiment. Asterisks refer to differences between 
treated and control va lues: ' p < 0.05; " p < 0.02. 
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Figure 6. Effect of beta-estradiol on the-tyrosinase activities and ce ll num-
bers of human me1anocytes. Melanocytes, seeded on to extracel lular matrix-
coated wells [1 8), were incubated for 24 h with beta-estradiol then assayed 
for tyros inase activity (A ) or counted (B). Bar heights indicate the mean 
± l SD for triplicate determinations from one representative experiment. 
Asterisks refer to differences between treated and control values: ' p < 0.05; 
" p < 0.02; " ' p < 0.005. 
gested that these effects reflect 1,25(OH}2Drmediated cell differ-
entiation [31 J. It is possible that culture in the presence ofPMA may 
cause the melanocytes to become more " undifferentiated" when 
compared with normal melanocytes from intact skin and this may 
alter the expression of l,25(OH}2D3 receptors. H owever, the avail-
able evidence suggests that melanocytes propagated in vitro by the 
mitoge ns PMA and CT are phenotypicall y stable and relatively well 
d ifferentiated [1 8]. The experiments reported here were performed 
after the removal of PM A and CT for 24-48 h. Under these condi-
Table I. Effect of Beta-estradiol on the Tyrosinase Activities of 
Human Melanocytes fr0111 Different Donors' 
Cell Line 
5/0109 
6/0109 
5/1108 
5/1812 
4/2501 
Tyrosinase Activity 
cprn / l02 cell / 4 h 
Control Beta-estradiol" 
418± 19 889 ± 29 ' 
483 ± 39 872 ± 159d 
1572 ± 108 2277 ± 141 ' 
548 ± 21 1015±60 f 
671 ± 12 965 ± 68 d 
• Refer to legend to Fig 6 for experime ntal detai l. 
% Increase 
213 
181 
145 
185 
144 
b The conccntration of beta-estradiol used in these experiments W"s 10- ' M . 
, P < 0.00 I , significa ntl y different fro l11 control va lues. 
d p < 0.02 , significantl y diffe rent from control values. 
, p < 0.01, sig nific",uly diffe rent from co ntro l va lues . 
( p < 0.005, significa ntl y different from control values. 
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tions the subsequent stat.e of differentiation in these cells, at least as 
assessed by tyrosinase activity, appears to be unaltered as only a small 
I change (a decrease of approximately 10% -15%) in the tyrosinase 
activity per cell occurs (Ranson, unpublished data). Furthermore, 
tyros inase responses to 1 ,25(OH)zD3 are similar whether PMA/CT 
has been removed for 1, 2, or 4 d (Ranson, unpublished data). 
Unlike melanoma cells, in the absence of PMA and CT the mela-
nocytes cease to proliferate [18]. It is difficult, therefore, to attribute 
the effect of 1,25(OH)2D3 (or beta-estradiol) on the numbers of 
attached ce lls to an inhibition of proliferation when, under the 
exp erimental conditions, no proliferation normally occurs. Thus 
the reason for the decrease in cell numbers in the presence of 
1,25(OH)2D3 or beta-estradiol is unclear. Although it is possible 
that either hormone is directly toxic to melanocytes, the negative 
correlation between tryosinase activity and cell numbers suggests an 
alte rnative explanation. Because the basal tyrosinase activity of mel-
anocytes is generally much higher than that of melanoma cells even 
modest increases in tyrosinase activity may result in the accumula-
tion of melanin precursors that are cytotoxic [32]. 
Our results are not in agreement with those of Tomita et al [33] 
who showed that a 6-d incubation with vitamin D3 but not 
1,25(OH)zD3 caused an increase in the amount of tyrosinase in 
humanmelanocytes. However, the tyrosinase measurements in that 
study were expressed as units of relative staining intensity and were 
not corrected for cel l numbers or protein concentrations. Further-
more, in the experiments of Tomita et al [33] melanocytes were 
Cultured under PMA-free conditions for 9 d. Our studies using a 
similar system indicate a marked decrease in cell numbers under 
these conditions after even 5 d [18]. 
The production of vitamin D 3 [the precursor of 1,25(OH)2D3] 
under the influence of ultraviolet light is diminished by the pres-
en ce of melanin [34]. Colston et al [6] and Kuroki [28] have sug-
ges ted that 1 ,25(OH)2D3 may act in a negative feedback manner to 
reduce the photo-conversion of 7-dehydro-cholesterol to vitamin 
D 3 · Our results , which indicate that 1,25(OH)2D 3 stimulates tyro-
sinase activity in melanocytes from normal skin, provide some evi-
dence to substantiate this hypothesis and further support the theory 
th at 1,25(OH)2D 3 is involved in the differentiation and develop-
ment of skin [28] . 
Some murine and human melanoma cell lines respond to a-MSH 
with large increases in cAMP followed by large increases in tyrosin-
ase activity [14]. However, there are conflicting data concerning the 
presence or otherwise of direct effects of a-MSH on normal mela-
nocytes. Nielsen and Don [35] , on the basis of unpublished data, 
reported that a-MSH enhanced the tyrosinase activity of human 
melanocytes, whereas Ha laban et al [21], who detected no effects, 
speculated that this phenomenon might be due to an inability of 
C\'-MSH to increase intracellular cAMP concentrations in melano-
cytes. Our studies indicate that this postulated mechanism is incor-
rect. However, the large increases in intracellular cAMP concentra-
tions were followed by only small increases in tyrosinase, a 
discrepancy that has also been described in relation to some mela-
noma cell s [36]. The demonstrated effects of a-MSH in vivo may be 
due to the presence of potentiating factors [37] that have yet to be 
idemified. It is possibl e that other fragm ents of the pro-opiomelan-
ocortin precursor also have direct effects on human melanocyte 
activity. 
The presence of es trogen receptors was described in human mela-
noma cells many years ago [13,38,39] though the fun ctional signifi-
can ce of these receptors has remained somewhat controversial [40 -
42J. To our knowledge, these are the first studies to show a direct 
biologic effect of an estrogen on normal melanocytes. The concen-
trations employed were in the physiologic range seen in pregnancy 
[43 J and the estradiol-induced increase in tyrosinase may help to 
explain pregnancy-associated pigmentation. 
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